autologous gp96 vaccination
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT02133079)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- EndoplasminImmunity, active
HSP90B1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous gp96 vaccination
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02317471 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2014 | Cure&Sure Biotech Co., LTD, People's Liberation Army of China |
| NCT02133079 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2012 | Chinese Academy of Medical Sciences, Cure&Sure Biotech Co., LTD |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cure&Sure Biotech Co., LTD | For profit | 2 | 1 | 1 | 2012 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2012 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1